A phase II trial of oral panobinostat (LBH589), a no deacetylase inhibitor (DACi) in patients with primary myelofibrosis (PMF), post-essential thrombocythemia (ET) myelofibrosis, and post-polycythemia vera (PV) myelofibrosis

被引：1
|
作者：
DeAngelo, D. J.
Tefferi, A.
Mesa, R. A.
Paley, C. S.
Wadleigh, M.
Snyder, D.
Ondovik, M. S.
Rine, J.
Bhalla, K. N.
机构：
[1] Harvard Univ, Dana Farber Canc Inst, Boston, MA 02115 USA
[2] Mayo Clin Rochester, Rochester, MN USA
[3] Mayo Clin Arizona, Scottsdale, AZ USA
[4] Novartis Pharmaceut, E Hanover, NJ USA
[5] City Hope Natl Med Ctr, Duarte, CA USA
[6] Med Coll Georgia, Ctr Canc, Augusta, GA 30912 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2010年 / 28卷 / 15期
关键词：
D O I：
10.1200/jco.2010.28.15_suppl.tps283
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TPS283
引用
收藏
页数：1
相关论文
共 50 条
  • [31] A Phase I Study of XL019, a Selective JAK2 Inhibitor, in Patients with Primary Myelofibrosis, Post-Polycythemia Vera, or Post-Essential Thrombocythemia Myelofibrosis
    Shah, Neil P.
    Olszynski, Patrycja
    Sokol, Lubomir
    Verstovsek, Srdan
    Hoffman, Ronald
    List, Alan F.
    Cortes, Jorge
    Kantadian, Hagop M.
    Gilliland, D. Gary
    Clary, Douglas O.
    Bui, Lynne A.
    Wadleigh, Martha
    BLOOD, 2008, 112 (11) : 44 - 44
  • [32] An Individual Patient Supply Program for Ruxolitinib for the Treatment of Patients with Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (PPV-MF), or Post-Essential Thrombocythemia Myelofibrosis (PET-MF)
    Barosi, Giovanni
    Agarwal, Mohan
    Zweegman, Sonja
    Willenbacher, Wolfgang
    Pakstyte, Sima
    Raymakers, Reinier
    Cantoni, Nathan
    Modi, Ankur
    Khan, Mahmudul
    Perez, Jose Ricardo
    Hasselbalch, Hans
    Vargas Viveros, Jose Pablo
    Linardi, Camila C. G.
    Gisslinger, Heinz
    Daumas Gabriel, Adelmo Henrique
    Palandri, Francesca
    Lavie, David
    Harrison, Claire N.
    BLOOD, 2012, 120 (21)
  • [33] A phase I/II study of INCB018424, an oral, selective JAK inhibitor, in patients with primary myelofibrosis (PMF) and post polycythemia vera/essential thrombocythemia myelofibrosis (Post-PV/ET MF)
    Verstovsek, S.
    Kantarjian, H. M.
    Pardanani, A.
    Thomas, D. A.
    Cortes, J. E.
    Mesa, R.
    Hogan, W.
    Redman, J.
    Levy, R.
    Vaddi, K.
    Tefferi, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [34] Prediction of thrombosis in post-polycythemia vera and post-essential thrombocythemia myelofibrosis: a study on 1258 patients
    Barbara Mora
    Paola Guglielmelli
    Andrew Kuykendall
    Elisa Rumi
    Margherita Maffioli
    Francesca Palandri
    Valerio De Stefano
    Marianna Caramella
    Silvia Salmoiraghi
    Jean-Jacques Kiladjian
    Jason Gotlib
    Alessandra Iurlo
    Francisco Cervantes
    Marco Ruggeri
    Richard T. Silver
    Francesco Albano
    Giulia Benevolo
    David M. Ross
    Matteo G. Della Porta
    Timothy Devos
    Giada Rotunno
    Rami S. Komrokji
    Ilaria C. Casetti
    Michele Merli
    Marco Brociner
    Domenica Caramazza
    Giuseppe Auteri
    Tiziano Barbui
    Daniele Cattaneo
    Lorenza Bertù
    Luca Arcaini
    Alessandro M. Vannucchi
    Francesco Passamonti
    Leukemia, 2022, 36 : 2453 - 2460
  • [35] The Use of Erythropoietic-Stimulating Agents (ESAs) with Ruxolitinib in Patients with Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (PPV-MF), and Post-Essential Thrombocythemia Myelofibrosis (PET-MF)
    McMullin, Mary Frances
    Harrison, Claire N.
    Niederwieser, Dietger
    Demuynck, Hilde
    Jakel, Nadja
    Sirulnik, Andres
    McQuity, Mari
    Stalbovskaya, Viktoriya
    Recher, Christian
    Theunissen, Koen
    Gisslinger, Heinz
    Kiladjian, Jean-Jacques
    Al-Ali, Haifa-Kathrin
    BLOOD, 2012, 120 (21)
  • [36] Real-world clinical characteristics of post-essential thrombocythemia and post-polycythemia vera myelofibrosis
    Shide, Kotaro
    Takenaka, Katsuto
    Kitanaka, Akira
    Numata, Akihiko
    Kameda, Takuro
    Yamauchi, Takuji
    Inagaki, Atsushi
    Mizuno, Shohei
    Takami, Akiyoshi
    Ito, Shinichi
    Hagihara, Masao
    Usuki, Kensuke
    Maekawa, Takaaki
    Sunami, Kazutaka
    Ueda, Yasunori
    Tsutsui, Miyuki
    Ando, Miki
    Komatsu, Norio
    Ozawa, Keiya
    Kurokawa, Mineo
    Arai, Shunya
    Mitani, Kinuko
    Akashi, Koichi
    Shimoda, Kazuya
    ANNALS OF HEMATOLOGY, 2024, 103 (01) : 97 - 103
  • [37] Allogeneic Hematopoietic Stem Cell Transplantation for Post-essential Thrombocythemia and Post-polycythemia Vera Myelofibrosis
    Murata, Makoto
    Suzuki, Ritsuro
    Nishida, Tetsuya
    Shirane, Shuichi
    Shimazu, Yutaka
    Minami, Yosuke
    Mori, Takehiko
    Doki, Noriko
    Kanda, Yoshinobu
    Uchida, Naoyuki
    Tanaka, Masatsugu
    Ishikawa, Jun
    Togitani, Kazuto
    Fukuda, Takahiro
    Ichinohe, Tatsuo
    Atsuta, Yoshiko
    Nagamura-Inoue, Tokiko
    Kiyoi, Hitoshi
    INTERNAL MEDICINE, 2020, 59 (16) : 1947 - 1956
  • [38] Real-world clinical characteristics of post-essential thrombocythemia and post-polycythemia vera myelofibrosis
    Kotaro Shide
    Katsuto Takenaka
    Akira Kitanaka
    Akihiko Numata
    Takuro Kameda
    Takuji Yamauchi
    Atsushi Inagaki
    Shohei Mizuno
    Akiyoshi Takami
    Shinichi Ito
    Masao Hagihara
    Kensuke Usuki
    Takaaki Maekawa
    Kazutaka Sunami
    Yasunori Ueda
    Miyuki Tsutsui
    Miki Ando
    Norio Komatsu
    Keiya Ozawa
    Mineo Kurokawa
    Shunya Arai
    Kinuko Mitani
    Koichi Akashi
    Kazuya Shimoda
    Annals of Hematology, 2024, 103 : 97 - 103
  • [39] Validation of the Myelofibrosis Secondary to PV and ET-Prognostic Model in Newly Diagnosed Patients with Post-Polycythemia Vera and Post-Essential Thrombocythemia Myelofibrosis: MD Anderson Cancer Center
    Masarova, Lucia
    Kantarjian, Hagop
    Verstovsek, Srdan
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 (10): : S20 - S21
  • [40] A phase II study of 5-azacitidine for patients with primary and post-essential thrombocythemia/polycythemia vera myelofibrosis
    Quintas-Cardama, A.
    Tong, W.
    Kantarjian, H.
    Thomas, D.
    Ravandi, F.
    Kornblau, S.
    Manshouri, T.
    Cortes, J. E.
    Garcia-Manero, G.
    Verstovsek, S.
    LEUKEMIA, 2008, 22 (05) : 965 - 970
12345